Tube Investments of India Ltd (TIINDIA) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Updated August 14, 2026 4 min read

Tube Investments of India, a key player in engineering, mobility, and emerging electric vehicle solutions, faces a pivotal quarter as it balances core business growth with aggressive capital allocation into new-age verticals. Investors will be watching for the trajectory of EV volume recovery following supply chain bottlenecks and the initial revenue contribution from the newly commissioned Naidupet CDMO facility.

Quick Details
Results dateAugust 14, 2026
QuarterQ1 FY 2026-2027
Previous quarter revenueRs. 2,279 Cr
Previous quarter PATRs. 361 Cr
Market capRs. 53,424.03 Cr
CMPRs. 2,759.9

Tube Investments of India Ltd Q1 Results Date and Time

The board is scheduled to meet on 14 August 2026 to approve the unaudited financial results for the quarter ended 30 June 2026.

An earnings conference call is scheduled for 17 August 2026 at 10:00 AM IST with IIFL Capital, featuring senior management participation.

What to expect from Tube Investments of India Ltd's Q1 FY27 results

Management maintains confidence in achieving double-digit growth for the standalone business, citing strong cost efficiencies despite ongoing US tariff uncertainties that impacted exports by approximately 10% in the previous quarter. The company is actively scaling its medical devices segment, targeting a 25% CAGR, with the newly acquired Medicura facility expected to bolster wound care growth toward the 15-20% target range. Meanwhile, the electric vehicle division is focused on purpose-built platforms, with leadership aiming for a path to breakeven for heavy vehicles and three-wheelers over the next 12 to 18 months. The upcoming call will likely address the impact of GST-driven competitive pressures in the three-wheeler segment and the progress of Vande Bharat coach order execution.

Key Things To Watch

Performance vs Guidance Tracking: Monitoring progress against previously communicated targets for core and growth segments.

  • Standalone PBT growth — 12% to 14% target — ongoing
  • Three-wheeler supply chain — full production capacity by Q1 FY27 — status pending
  • Railway business revenue — expected Q1 FY27 — status pending
  • CDMO Naidupet facility — commercial production in Q1 FY27 — status pending

EV Business Operational Focus: Evaluating the recovery and expansion of the electric vehicle portfolio.

  • Recovery in three-wheeler volumes following Q4 FY26 drop to 1,176 units
  • Update on heavy vehicle and three-wheeler breakeven path within 12-18 month window
  • Status of product launches including Tipper, 4x2 variants, and swap technology

Medical Devices and CDMO Execution: Tracking the contribution of new assets and growth verticals.

  • Revenue impact from Medicura IV cannula asset integration in Q1 FY27
  • Commercial production status at the Naidupet CDMO facility

Risks and Headwinds to Monitor: Assessing external factors impacting margins and growth.

  • Impact of GST reduction on ICE three-wheeler competitive pricing
  • US tariff impact on export segments representing 4-5% of revenue
  • Commodity price inflation and fuel cost pass-through effectiveness

Frequently Asked Questions

What is the current status of the EV three-wheeler supply chain?

Management acknowledged supply chain bottlenecks in the previous period and expected to reach full production capacity by Q1 FY27. Investors are looking for volume recovery in the current results compared to the 1,176 units reported in Q4 FY26.

How is the company managing the impact of US tariffs on its exports?

Exports to the US slowed by about 10% in Q2 FY26 due to tariffs, affecting 4-5% of total revenue. Management noted that while near-term orders remain intact, the future outlook for the 25% export revenue target remains uncertain due to global trade policies.

What is the timeline for the EV business to reach breakeven?

Management stated that the heavy vehicle and three-wheeler segments are being pushed toward breakeven within the next 12 to 18 months. No specific breakeven timeline was provided for the small commercial vehicle or e-tractor segments.

Is the standalone business revenue growing?

Standalone revenue rose to Rs. 2,279 Cr in Q4 FY26 from Rs. 1,957 Cr in the same quarter of the previous year, representing a 16.5% YoY increase. Management maintains a long-term double-digit growth thesis for the standalone business despite export headwinds.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now